These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32641023)

  • 21. Rationale and design of extended cancer education for longer term survivors (EXCELS): a randomized control trial of 'high touch' vs. 'high tech' cancer survivorship self-management tools in primary care.
    Davis SN; O'Malley DM; Bator A; Ohman-Strickland P; Clemow L; Ferrante JM; Crabtree BF; Miller SM; Findley P; Hudson SV
    BMC Cancer; 2019 Apr; 19(1):340. PubMed ID: 30971205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
    Hoffman RM; Lo M; Clark JA; Albertsen PC; Barry MJ; Goodman M; Penson DF; Stanford JL; Stroup AM; Hamilton AS
    J Clin Oncol; 2017 Jul; 35(20):2306-2314. PubMed ID: 28493812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol paper: Multi-site, cluster-randomized clinical trial for optimizing functional outcomes of older cancer survivors after chemotherapy.
    Yilmaz S; Janelsins MC; Flannery M; Culakova E; Wells M; Lin PJ; Loh KP; Epstein R; Kamen C; Kleckner AS; Norton SA; Plumb S; Alberti S; Doyle K; Porto M; Weber M; Dukelow N; Magnuson A; Kehoe LA; Nightingale G; Jensen-Battaglia M; Mustian KM; Mohile SG
    J Geriatr Oncol; 2022 Jul; 13(6):892-903. PubMed ID: 35292232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follow-up Care for Survivors of Prostate Cancer - Clinical Management: a Program in Evidence-Based Care Systematic Review and Clinical Practice Guideline.
    Loblaw A; Souter LH; Canil C; Breau RH; Haider M; Jamnicky L; Morash R; Surchin M; Matthew A
    Clin Oncol (R Coll Radiol); 2017 Nov; 29(11):711-717. PubMed ID: 28928084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trial.
    Watson E; Rose P; Frith E; Hamdy F; Neal D; Kastner C; Russell S; Walter FM; Faithfull S; Wolstenholme J; Perera R; Weller D; Campbell C; Wilkinson C; Neal R; Sooriakumaran P; Butcher H; Matthews M
    BMJ Open; 2014 May; 4(5):e005186. PubMed ID: 24852301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
    Burm R; Thewes B; Rodwell L; Kievit W; Speckens A; van de Wal M; Prins J
    BMC Cancer; 2019 May; 19(1):462. PubMed ID: 31096934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Home-based multidimensional survivorship programmes for breast cancer survivors.
    Cheng KKF; Lim YTE; Koh ZM; Tam WWS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population-Based Assessment of Determining Treatments for Prostate Cancer.
    Chamie K; Williams SB; Hu JC
    JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: OncoActive.
    Golsteijn RHJ; Bolman C; Volders E; Peels DA; de Vries H; Lechner L
    BMC Cancer; 2017 Jun; 17(1):446. PubMed ID: 28651586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner.
    Kenyon M; Mayer DK; Owens AK
    J Obstet Gynecol Neonatal Nurs; 2014; 43(3):382-98. PubMed ID: 24690072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
    Noels EC; Hollestein LM; van Egmond S; Lugtenberg M; van Nistelrooij LPJ; Bindels PJE; van der Lei J; Stern RS; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Sep; 181(3):544-553. PubMed ID: 30636037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.
    Wilt TJ; MacDonald R; Rutks I; Shamliyan TA; Taylor BC; Kane RL
    Ann Intern Med; 2008 Mar; 148(6):435-48. PubMed ID: 18252677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
    Eastham JA; Kelly WK; Grossfeld GD; Small EJ;
    Urology; 2003 Dec; 62 Suppl 1():55-62. PubMed ID: 14747042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SCORE: Shared care of Colorectal cancer survivors: protocol for a randomised controlled trial.
    Jefford M; Emery J; Grunfeld E; Martin A; Rodger P; Murray AM; De Abreu Lourenco R; Heriot A; Phipps-Nelson J; Guccione L; King D; Lisy K; Tebbutt N; Burgess A; Faragher I; Woods R; Schofield P
    Trials; 2017 Oct; 18(1):506. PubMed ID: 29084595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The BETTER WISE protocol: building on existing tools to improve cancer and chronic disease prevention and screening in primary care for wellness of cancer survivors and patients - a cluster randomized controlled trial embedded in a mixed methods design.
    Manca DP; Fernandes C; Grunfeld E; Aubrey-Bassler K; Shea-Budgell M; Lofters A; Campbell-Scherer D; Sopcak N; O'Brien MA; Meaney C; Moineddin R; McBrien K; Salvalaggio G; Krueger P
    BMC Cancer; 2018 Sep; 18(1):927. PubMed ID: 30257655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial.
    Perez J; Jin H; Russo DA; Stochl J; Painter M; Shelley G; Jackson E; Crane C; Graffy JP; Croudace TJ; Byford S; Jones PB
    Lancet Psychiatry; 2015 Nov; 2(11):984-93. PubMed ID: 26296562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
    Attard G; Murphy L; Clarke NW; Cross W; Jones RJ; Parker CC; Gillessen S; Cook A; Brawley C; Amos CL; Atako N; Pugh C; Buckner M; Chowdhury S; Malik Z; Russell JM; Gilson C; Rush H; Bowen J; Lydon A; Pedley I; O'Sullivan JM; Birtle A; Gale J; Srihari N; Thomas C; Tanguay J; Wagstaff J; Das P; Gray E; Alzoueb M; Parikh O; Robinson A; Syndikus I; Wylie J; Zarkar A; Thalmann G; de Bono JS; Dearnaley DP; Mason MD; Gilbert D; Langley RE; Millman R; Matheson D; Sydes MR; Brown LC; Parmar MKB; James ND;
    Lancet; 2022 Jan; 399(10323):447-460. PubMed ID: 34953525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supporting participation in paid work of cancer survivors and their partners in the Netherlands: protocol of the SusTained Employability in cancer Patients and their partnerS (STEPS) multi-centre randomized controlled trial and cohort study.
    Zegers AD; Coenen P; Bültmann U; Retèl V; Kieffer JM; van der Beek AJ; Duijts SFA
    BMC Public Health; 2021 Oct; 21(1):1844. PubMed ID: 34641839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study).
    Green A; Newton RU; Smith DP; Tuffaha H; Galvão DA; Heathcote P; Patel MI; Christie D; Egger S; Sara SA; Heneka N; Chambers SK; Dunn J
    BMJ Open; 2024 Mar; 14(3):e084412. PubMed ID: 38521521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
    Rosenberg JE; Jung JH; Edgerton Z; Lee H; Lee S; Bakker CJ; Dahm P
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013641. PubMed ID: 32813279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.